386 related articles for article (PubMed ID: 22014092)
1. Quantitative proteomics reveals metabolic and pathogenic properties of Chlamydia trachomatis developmental forms.
Saka HA; Thompson JW; Chen YS; Kumar Y; Dubois LG; Moseley MA; Valdivia RH
Mol Microbiol; 2011 Dec; 82(5):1185-203. PubMed ID: 22014092
[TBL] [Abstract][Full Text] [Related]
2. Impact of Active Metabolism on Chlamydia trachomatis Elementary Body Transcript Profile and Infectivity.
Grieshaber S; Grieshaber N; Yang H; Baxter B; Hackstadt T; Omsland A
J Bacteriol; 2018 Jul; 200(14):. PubMed ID: 29735758
[TBL] [Abstract][Full Text] [Related]
3. Quantitative Proteomics of the Infectious and Replicative Forms of Chlamydia trachomatis.
Skipp PJ; Hughes C; McKenna T; Edwards R; Langridge J; Thomson NR; Clarke IN
PLoS One; 2016; 11(2):e0149011. PubMed ID: 26871455
[TBL] [Abstract][Full Text] [Related]
4. Quantitative Protein Profiling of Chlamydia trachomatis Growth Forms Reveals Defense Strategies Against Tryptophan Starvation.
Østergaard O; Follmann F; Olsen AW; Heegaard NH; Andersen P; Rosenkrands I
Mol Cell Proteomics; 2016 Dec; 15(12):3540-3550. PubMed ID: 27784728
[TBL] [Abstract][Full Text] [Related]
5. Computational Modeling of the Chlamydial Developmental Cycle Reveals a Potential Role for Asymmetric Division.
Chiarelli TJ; Grieshaber NA; Appa C; Grieshaber SS
mSystems; 2023 Apr; 8(2):e0005323. PubMed ID: 36927072
[TBL] [Abstract][Full Text] [Related]
6. Single-Inclusion Kinetics of
Chiarelli TJ; Grieshaber NA; Omsland A; Remien CH; Grieshaber SS
mSystems; 2020 Oct; 5(5):. PubMed ID: 33051378
[TBL] [Abstract][Full Text] [Related]
7. The ClpX and ClpP2 Orthologs of Chlamydia trachomatis Perform Discrete and Essential Functions in Organism Growth and Development.
Wood NA; Blocker AM; Seleem MA; Conda-Sheridan M; Fisher DJ; Ouellette SP
mBio; 2020 Sep; 11(5):. PubMed ID: 32873765
[No Abstract] [Full Text] [Related]
8. Tag-Dependent Substrate Selection of ClpX Underlies Secondary Differentiation of Chlamydia trachomatis.
Wood NA; Swoboda AR; Blocker AM; Fisher DJ; Ouellette SP
mBio; 2022 Oct; 13(5):e0185822. PubMed ID: 36154190
[TBL] [Abstract][Full Text] [Related]
9. Phosphoproteomic analysis of the Chlamydia caviae elementary body and reticulate body forms.
Fisher DJ; Adams NE; Maurelli AT
Microbiology (Reading); 2015 Aug; 161(8):1648-1658. PubMed ID: 25998263
[TBL] [Abstract][Full Text] [Related]
10. Penicillin induced persistence in Chlamydia trachomatis: high quality time lapse video analysis of the developmental cycle.
Skilton RJ; Cutcliffen LT; Barlow D; Wang Y; Salim O; Lambden PR; Clarke IN
PLoS One; 2009 Nov; 4(11):e7723. PubMed ID: 19893744
[TBL] [Abstract][Full Text] [Related]
11. The Periplasmic Tail-Specific Protease, Tsp, Is Essential for Secondary Differentiation in
Swoboda AR; Wood NA; Saery EA; Fisher DJ; Ouellette SP
J Bacteriol; 2023 May; 205(5):e0009923. PubMed ID: 37092988
[TBL] [Abstract][Full Text] [Related]
12. Treatment of Chlamydia trachomatis with a small molecule inhibitor of the Yersinia type III secretion system disrupts progression of the chlamydial developmental cycle.
Wolf K; Betts HJ; Chellas-Géry B; Hower S; Linton CN; Fields KA
Mol Microbiol; 2006 Sep; 61(6):1543-55. PubMed ID: 16968227
[TBL] [Abstract][Full Text] [Related]
13. Three temporal classes of gene expression during the Chlamydia trachomatis developmental cycle.
Shaw EI; Dooley CA; Fischer ER; Scidmore MA; Fields KA; Hackstadt T
Mol Microbiol; 2000 Aug; 37(4):913-25. PubMed ID: 10972811
[TBL] [Abstract][Full Text] [Related]
14. Comparative proteome analysis of Chlamydia trachomatis serovar A, D and L2.
Shaw AC; Gevaert K; Demol H; Hoorelbeke B; Vandekerckhove J; Larsen MR; Roepstorff P; Holm A; Christiansen G; Birkelund S
Proteomics; 2002 Feb; 2(2):164-86. PubMed ID: 11840563
[TBL] [Abstract][Full Text] [Related]
15. Chlamydia trachomatis type III secretion: evidence for a functional apparatus during early-cycle development.
Fields KA; Mead DJ; Dooley CA; Hackstadt T
Mol Microbiol; 2003 May; 48(3):671-83. PubMed ID: 12694613
[TBL] [Abstract][Full Text] [Related]
16. Developmental stage-specific metabolic and transcriptional activity of Chlamydia trachomatis in an axenic medium.
Omsland A; Sager J; Nair V; Sturdevant DE; Hackstadt T
Proc Natl Acad Sci U S A; 2012 Nov; 109(48):19781-5. PubMed ID: 23129646
[TBL] [Abstract][Full Text] [Related]
17. The Chlamydia trachomatis type III secretion chaperone Slc1 engages multiple early effectors, including TepP, a tyrosine-phosphorylated protein required for the recruitment of CrkI-II to nascent inclusions and innate immune signaling.
Chen YS; Bastidas RJ; Saka HA; Carpenter VK; Richards KL; Plano GV; Valdivia RH
PLoS Pathog; 2014 Feb; 10(2):e1003954. PubMed ID: 24586162
[TBL] [Abstract][Full Text] [Related]
18. Expression and structure of the Chlamydia trachomatis DksA ortholog.
Mandel C; Yang H; Buchko GW; Abendroth J; Grieshaber N; Chiarelli T; Grieshaber S; Omsland A
Pathog Dis; 2022 May; 80(1):. PubMed ID: 35388904
[TBL] [Abstract][Full Text] [Related]
19. Identification and characterization of a novel Chlamydia trachomatis reticulate body protein.
Shaw AC; Larsen MR; Roepstorff P; Christiansen G; Birkelund S
FEMS Microbiol Lett; 2002 Jul; 212(2):193-202. PubMed ID: 12113934
[TBL] [Abstract][Full Text] [Related]
20. One Face of Chlamydia trachomatis: The Infectious Elementary Body.
Cossé MM; Hayward RD; Subtil A
Curr Top Microbiol Immunol; 2018; 412():35-58. PubMed ID: 27197644
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
